Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
7.21
+0.07 (0.98%)
At close: Jun 27, 2025, 4:00 PM
7.00
-0.21 (-2.91%)
After-hours: Jun 27, 2025, 5:39 PM EDT
Aligos Therapeutics Employees
Aligos Therapeutics had 70 employees as of December 31, 2024. The number of employees increased by 4 or 6.06% compared to the previous year.
Employees
70
Change (1Y)
4
Growth (1Y)
6.06%
Revenue / Employee
$46,714
Profits / Employee
-$760,857
Market Cap
44.09M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ALGS News
- 9 days ago - Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC) - GlobeNewsWire
- 14 days ago - Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Aligos Therapeutics to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Aligos Therapeutics Appoints Laura Kavanaugh as Vice President, Head of Legal - GlobeNewsWire
- 7 weeks ago - Aligos Therapeutics Presents Positive Data at the EASL Congress 2025 - GlobeNewsWire
- 7 weeks ago - Aligos Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Aligos Therapeutics to Announce 1st Quarter 2025 Financial Results on May 6, 2025 - GlobeNewsWire
- 2 months ago - Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025 - GlobeNewsWire